Ginkgo Bioworks
Twist Bioscience Nabs Long DNA IP in Renegotiated Ginkgo Bioworks Contract
The three-year $15 million agreement replaces a 2022 deal between the firms, which have been business partners since at least 2017.
Ginkgo Updates 2025 Guidance Following Q1 Boost From Deferred Revenue
A 27 percent Q1 revenue increase was mainly driven by the release of $7 million in noncash deferred revenue from a terminated customer agreement.
GenomeWeb Top 40 Falls 5 Percent in April Amidst Mixed Broader Market
The Dow Jones Industrial Average fell 3 percent while the Nasdaq and the Nasdaq Biotech Index each rose by less than 1 percent.
Ginkgo Bioworks, Plex Research Partner on AI-Based Drug Discovery
Plex Research will analyze a large-scale transcriptomics dataset from Ginkgo Datapoints that measures compound-induced gene expression across diverse human cell types.
GenomeWeb Top 40 Plummets 14 Percent in February as Government Spending Concerns Loom
The Dow Jones Industrial Average fell 2 percent, the Nasdaq fell 4 percent, and the Nasdaq Biotech Index declined by less than 1 percent.
Jun 25, 2024
Ginkgo Bioworks to Lay off 35 Percent of Workforce
May 15, 2024
BTIG Downgrades Ginkgo Bioworks to Sell Rating
Mar 1, 2024